Drug for celiac disease shows promise in treating severe post-COVID syndrome in children

/ Research update / / ,

by Mass General Brigham edited by Stephanie Baum, reviewed by Andrew Zinin Credit: Pixabay/CC0 Public Domain In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID. Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition […]

Drug for celiac disease shows promise in treating severe post-COVID syndrome in children Read More »